Minjie Wei

6.8k total citations · 4 hit papers
83 papers, 5.5k citations indexed

About

Minjie Wei is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Minjie Wei has authored 83 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 18 papers in Pathology and Forensic Medicine and 15 papers in Physiology. Recurrent topics in Minjie Wei's work include Alzheimer's disease research and treatments (14 papers), DNA Repair Mechanisms (6 papers) and Vitamin D Research Studies (6 papers). Minjie Wei is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), DNA Repair Mechanisms (6 papers) and Vitamin D Research Studies (6 papers). Minjie Wei collaborates with scholars based in China, United States and United Kingdom. Minjie Wei's co-authors include Yan Chun Li, Juan Kong, Zhou‐Feng Chen, Liping Cao, Shu Q. Liu, Liping Cao, Mingyan Liu, Xin Zhong, Weifan Yao and Ke Du and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Cancer Cell.

In The Last Decade

Minjie Wei

81 papers receiving 5.3k citations

Hit Papers

1,25-Dihydroxyvitamin D3 is a negative endocrine regulato... 2002 2026 2010 2018 2002 2002 2019 2022 500 1000 1.5k

Peers

Minjie Wei
Raymond J. MacAllister United Kingdom
Paolo Fanti United States
Dale A. Parks United States
León Ferder Argentina
Minjie Wei
Citations per year, relative to Minjie Wei Minjie Wei (= 1×) peers Edilia Tapia

Countries citing papers authored by Minjie Wei

Since Specialization
Citations

This map shows the geographic impact of Minjie Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjie Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjie Wei more than expected).

Fields of papers citing papers by Minjie Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minjie Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjie Wei. The network helps show where Minjie Wei may publish in the future.

Co-authorship network of co-authors of Minjie Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Minjie Wei. A scholar is included among the top collaborators of Minjie Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minjie Wei. Minjie Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hui, Y. H., Yue Han, Yanli Cao, et al.. (2025). Indoleamine-2,3-dioxygenase: An important controller in maintaining mesenchymal stem cell-mediated immunomodulatory homeostasis. Acta Pharmaceutica Sinica B. 15(7). 3404–3418. 1 indexed citations
2.
Zhang, Xi, Xiao Hu, Chen Fu, et al.. (2025). Novel MAFG-METTL14-SCD1 axis regulates lipid metabolism mediating choroidal melanoma distant metastasis. Journal of Experimental & Clinical Cancer Research. 44(1). 334–334.
3.
Tong, Winnie, et al.. (2024). Endosomal traffic disorders: a driving force behind neurodegenerative diseases. Translational Neurodegeneration. 13(1). 66–66. 6 indexed citations
4.
Wang, Xinqiao, Yuxin Li, Shuhui Zhang, et al.. (2024). Novel insight and perspectives of nanoparticle-mediated gene delivery and immune-modulating therapies for pancreatic cancer. Journal of Nanobiotechnology. 22(1). 771–771. 4 indexed citations
5.
Zhong, Xin, Shiqiang Gong, Linghui Meng, et al.. (2024). Cordycepin Modulates Microglial M2 Polarization Coupled with Mitochondrial Metabolic Reprogramming by Targeting HKII and PDK2. Advanced Science. 11(31). e2304687–e2304687. 26 indexed citations
6.
Miao, Yuxi, et al.. (2024). Current status and trends in small nucleic acid drug development: Leading the future. Acta Pharmaceutica Sinica B. 14(9). 3802–3817. 25 indexed citations
8.
Yu, Zhihua, Xin Zhong, Weifan Yao, et al.. (2022). Cordycepin improved neuronal synaptic plasticity through CREB-induced NGF upregulation driven by MG-M2 polarization: a microglia-neuron symphony in AD. Biomedicine & Pharmacotherapy. 157. 114054–114054. 12 indexed citations
9.
Yu, Jiankun, Shanshan Wang, Jing Qi, et al.. (2021). Mannose-modified liposome designed for epitope peptide drug delivery in cancer immunotherapy. International Immunopharmacology. 101(Pt A). 108148–108148. 23 indexed citations
11.
Han, Qiang, Mingli Sun, Wensi Liu, et al.. (2019). <p>Upregulated expression of ACTL8 contributes to invasion and metastasis and indicates poor prognosis in colorectal cancer</p>. OncoTargets and Therapy. Volume 12. 1749–1763. 11 indexed citations
12.
Wei, Binbin, Mingyan Liu, Zaixing Chen, & Minjie Wei. (2018). Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain. Acta Pharmacologica Sinica. 39(4). 616–625. 34 indexed citations
13.
Wang, Shuang, et al.. (2016). Regulation of human cardiac Kv1.5 channels by extracellular acidification. Pflügers Archiv - European Journal of Physiology. 468(11-12). 1885–1894. 1 indexed citations
14.
Zhong, Xin, Mingyan Liu, Xiaohong Sun, & Minjie Wei. (2016). Association between ABCB1 polymorphisms and haplotypes and Alzheimer’s disease: a meta-analysis. Scientific Reports. 6(1). 32708–32708. 18 indexed citations
15.
Wu, Huizhe, Shu Guan, Mingli Sun, et al.. (2015). Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment. PLoS ONE. 10(5). e0126128–e0126128. 36 indexed citations
16.
Jin, Xin, Mingyan Liu, Zaixing Chen, et al.. (2015). Separation and purification of epigallocatechin-3-gallate (EGCG) from green tea using combined macroporous resin and polyamide column chromatography. Journal of Chromatography B. 1002. 113–122. 36 indexed citations
17.
Sun, Mingli, Shuang Wang, Lin Zhao, et al.. (2013). Suppression of 2,4-dinitrochlorobenzene-induced atopic dermatitis by extract of Bacillus Calmette-Guerin. Molecular Medicine Reports. 9(2). 689–694. 4 indexed citations
18.
Bai, Xuefeng, Feng Jin, Zhaojin Yu, et al.. (2011). Clinicopathological significance and prognostic value of Xeroderma pigmentosum complementary group C (XPC) expression in sporadic breast cancer patients. Medical Oncology. 29(3). 1543–1553. 2 indexed citations
19.
Kong, Juan, Gene Kim, Minjie Wei, et al.. (2010). Therapeutic Effects of Vitamin D Analogs on Cardiac Hypertrophy in Spontaneously Hypertensive Rats. American Journal Of Pathology. 177(2). 622–631. 81 indexed citations
20.
Li, Yan Chun, Juan Kong, Minjie Wei, et al.. (2002). 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. Journal of Clinical Investigation. 110(2). 229–238. 1298 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026